Recommendations for reporting morbid events after heart valve surgery.

医学 观察研究 不利影响 并发症 急诊医学 机械心脏 重症监护医学 医疗急救 外科 内科学
作者
Dieter Horstkotte,M Lengyel,Wilhelm Mistiaen,Cornelia Piper,Heinz Völler
出处
期刊:PubMed [National Institutes of Health]
卷期号:14 (1): 1-7 被引量:13
链接
标识
摘要

Major reasons for the considerable heterogeneity among published results of heart valve surgery are inconsistency in follow up techniques, reporting systems and classification of adverse events. The present recommendations are intended to harmonize the presentation of clinical material in order to improve comparison of data from different sources for the analysis of pooled data. The quality of an observational study is largely, if not entirely, due to the follow up technique, which may be graded according to six categories: Self-reporting of adverse events/well-being by the patients may be classified 'excellent'; if the information is gathered and re-checked at short-term intervals. Data obtained from in-hospital or outpatient examinations by qualified examiners at least twice a year or other personal contact through qualified examiners may be regarded as 'sufficient', if the results are re-checked by contacting the treating home physician. All other follow up techniques may be regarded as inappropriate. Consequences of complications are entirely dependent on severity and possible sequelae. It is therefore recommended to grade any reported complication according to its severity by utilizing a score system. Embolisms are best categorized by utilizing the performance status scale. Bleeding events may be categorized according to severity as fatal, major (requiring hospital transmission with transfusion, surgery or with permanently increased disability) or minor (not requiring hospital admission, surgery or transfusion). In some cases it will remain unclear whether an event was primarily embolic or hemorrhagic. These complications should be summarized as 'not categorized'. The reporting of morbid events due to thrombosis, embolism and bleeding should go along with information regarding the quality of antithrombotic management.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Yidong发布了新的文献求助30
1秒前
墨沫完成签到,获得积分10
3秒前
3秒前
仲夏夜之梦完成签到,获得积分10
4秒前
KaFe发布了新的文献求助10
4秒前
小二郎应助Lais采纳,获得10
5秒前
852应助南城采纳,获得10
5秒前
外向沅发布了新的文献求助10
6秒前
闪闪机器猫应助SunS采纳,获得10
6秒前
高高菠萝完成签到 ,获得积分10
7秒前
阿鑫发布了新的文献求助10
7秒前
陈奕宏发布了新的文献求助10
8秒前
脑洞疼应助YuanzhiZhang采纳,获得10
9秒前
10秒前
TIMPs发布了新的文献求助10
10秒前
10秒前
充电宝应助科研通管家采纳,获得10
12秒前
Ava应助科研通管家采纳,获得10
13秒前
思源应助科研通管家采纳,获得10
13秒前
小二郎应助科研通管家采纳,获得10
13秒前
蜉蝣完成签到,获得积分10
13秒前
赘婿应助科研通管家采纳,获得10
13秒前
NexusExplorer应助科研通管家采纳,获得10
13秒前
小刘同学完成签到,获得积分10
13秒前
汉堡包应助科研通管家采纳,获得10
13秒前
13秒前
烟花应助科研通管家采纳,获得10
13秒前
14秒前
无极微光应助科研通管家采纳,获得20
14秒前
顾矜应助科研通管家采纳,获得10
14秒前
14秒前
共享精神应助科研通管家采纳,获得10
14秒前
14秒前
14秒前
molihuakai应助科研通管家采纳,获得10
14秒前
ding应助科研通管家采纳,获得80
14秒前
14秒前
sinFlee发布了新的文献求助10
14秒前
Orange应助科研通管家采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Physiologic specialization in Peronospora manshurica 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7777040
求助须知:如何正确求助?哪些是违规求助? 9318227
关于积分的说明 20362977
捐赠科研通 7364139
什么是DOI,文献DOI怎么找? 3318830
关于科研通互助平台的介绍 2466494
邀请新用户注册赠送积分活动 2334013